Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality study cross sectional study

被引:151
作者
Moja, LP
Telaro, E
D'Amico, R
Moschetti, I
Coe, L
Liberati, A [1 ]
机构
[1] Univ Modena & Reggio Emilia, Modena, Italy
[2] Ist Ric Farmacol Mario Negri, Ctr Cochrane Italiano, I-20157 Milan, Italy
来源
BMJ-BRITISH MEDICAL JOURNAL | 2005年 / 330卷 / 7499期
关键词
D O I
10.1136/bmj.38414.515938.8F
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To describe how the methodological quality of primary studies is assessed in systematic reviews and whether the quality assessment is taken into account in the interpretation of results. Data sources Cochrane systematic reviews and systmatic reviews in paper based journals. Study selection 965 systematic reviews (809 Cochrane reviews and 156 paper based reviews) published between 1995 and 2002. Data synthesis. The methodological quality of primary studies was assessed in 8 54 of the 965 systematic reviews (88.5%). This occurred more often in Cochrane reviews than in paper based reviews (93.9% v 60.3%, P < 0.0001). Overall, only 496 (51.4%) used the quality assessment in the analysis and interpretation of die results or in their discussion, with no significant differences between Cochrane reviews and paper based reviews (52% v 49%, P = 0.58). The tools and methods used for quality assessment varied widely. Conclusions Cochrane reviews fared better than systematic reviews published-in paper based journals in terms of assessment of methodological quality of primary studies, although they both largely failed to take it into account in the interpretation of results. Methods for assessment of methodological quality by systematic reviews are still in. their infancy and there is substantial room for improvement.
引用
收藏
页码:1053 / 1055
页数:7
相关论文
共 41 条
[1]   RANDOMIZATION AND BASE-LINE COMPARISONS IN CLINICAL-TRIALS [J].
ALTMAN, DG ;
DORE, CJ .
LANCET, 1990, 335 (8682) :149-153
[2]  
[Anonymous], SYSTEMATIC REV HLTH
[3]   Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials [J].
Balk, EM ;
Bonis, PAL ;
Moskowitz, H ;
Schmid, CH ;
Ioannidis, JPA ;
Wang, CC ;
Lau, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (22) :2973-2982
[4]   Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].
Begg, C ;
Cho, M ;
Eastwood, S ;
Horton, R ;
Moher, D ;
Olkin, I ;
Pitkin, R ;
Rennie, D ;
Schulz, KF ;
Simel, D ;
Stroup, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639
[5]  
BROWN SA, 1991, NURS RES, V40, P352
[6]   BIAS, PREVALENCE AND KAPPA [J].
BYRT, T ;
BISHOP, J ;
CARLIN, JB .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (05) :423-429
[7]   A METHOD FOR ASSESSING THE QUALITY OF A RANDOMIZED CONTROL TRIAL [J].
CHALMERS, TC ;
SMITH, H ;
BLACKBURN, B ;
SILVERMAN, B ;
SCHROEDER, B ;
REITMAN, D ;
AMBROZ, A .
CONTROLLED CLINICAL TRIALS, 1981, 2 (01) :31-49
[8]   INSTRUMENTS FOR ASSESSING THE QUALITY OF DRUG STUDIES PUBLISHED IN THE MEDICAL LITERATURE [J].
CHO, MK ;
BERO, LA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (02) :101-104
[9]   Assessing the quality of randomized trials:: Reliability of the Jadad scale [J].
Clark, HD ;
Wells, GA ;
Huët, C ;
McAlister, FA ;
Salmi, LR ;
Fergusson, D ;
Laupacis, A .
CONTROLLED CLINICAL TRIALS, 1999, 20 (05) :448-452
[10]   HOW STUDY DESIGN AFFECTS OUTCOMES IN COMPARISONS OF THERAPY .1. MEDICAL [J].
COLDITZ, GA ;
MILLER, JN ;
MOSTELLER, F .
STATISTICS IN MEDICINE, 1989, 8 (04) :441-454